AMP-activated protein kinase: A target for drugs both ancient and modern

216Citations
Citations of this article
189Readers
Mendeley users who have this article in their library.

Abstract

The AMP-activated protein kinase (AMPK) is a sensor of cellular energy status. It is activated, by a mechanism requiring the tumor suppressor LKB1, by metabolic stresses that increase cellular ADP:ATP and/or AMP:ATP ratios. Once activated, it switches on catabolic pathways that generate ATP, while switching off biosynthetic pathways and cell-cycle progress. These effects suggest that AMPK activators might be useful for treatment and/or prevention of type 2 diabetes and cancer. Indeed, AMPK is activated by the drugs metformin and salicylate, the latter being the major breakdown product of aspirin. Metformin is widely used to treat diabetes, while there is epidemiological evidence that both metformin and aspirin provide protection against cancer. We review the mechanisms of AMPK activation by these and other drugs, and by natural products derived from traditional herbal medicines. © 2012 Elsevier Ltd.

Cite

CITATION STYLE

APA

Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012, October 26). AMP-activated protein kinase: A target for drugs both ancient and modern. Chemistry and Biology. https://doi.org/10.1016/j.chembiol.2012.08.019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free